Recent developments within the US Department of Health and Human Services (HHS) have sparked debate over mRNA vaccine research. The agency at the helm of Robert F. Kennedy Jr., has hoped that funding cuts for mRNA research would continue after cancelling grants for vaccine reluctance research. However, HHS has confirmed that no such cuts have occurred.
The National Institutes of Health (NIH), an HHS organization focusing on biomedical research, continues to fund at least 130 studies on mRNA technology. This covers influenza, HIV, cancer and other conditions.
rub mRNA mentions from grants
Speculations surged after reports came about that NIH officials allegedly told scientists to remove mRNA references from grant applications. Some saw it as a signal that the government was planning to cut funds.
KFF Health News defeated the story. The report says NIH-funded scientists were told to “scrub” the “scrub” reference to mRNA vaccine technology from the application.
According to an email reviewed by KFF, NIH Project officials have “flagrated” pending grants to mention mRNA. Researchers at the Philadelphia Center for Biomedical Medicine wrote, “It remains to be seen whether the mRNA vaccine grant will be cancelled.”
Meanwhile, NIH officials have directed senior New York scientists who have cited the effectiveness of the mRNA vaccine in past applications to remove all mentions of mRNA from future proposals.
KFF also said that officials at the National Cancer Institute (NCI) have confirmed that NIH representative Matthew Memoli has sent an institute-wide email to direct staff.
Grants, contracts, or collaborations that include mRNA vaccines report the chain to the office of Robert F. Kennedy Jr., Secretary of Health and Human Services, and the White House.
This follows the NIH's decision to cancel vaccine reluctance research. “It's reasonable to assume that mRNA vaccine work is next,” an NIH official told The Outlet.
These revelations sparked the mainstream media outlets with rage, but they have completely missed it for that reason. Instead of addressing the risks of mRNA technology, they framed the issue as an attack on science launched by the new administration.
Scientific American declared, “Lifesaving mRNA vaccine technology appears to be targeted under Trump and RFK Jr..” Meanwhile, socialist websites around the world have denounced the ideological purge that is expected in the headline: “NIH's crackdown on mRNA research: Trump administration's march towards scientific censorship.” Bloomberg lamented the victory of misinformation, warning that “the anti-Vax culture war against mRNA has worsened.”
These stories ignore evidence that increases the safety risk of mRNA. Nor was the mention of the strong biotechnology bond within the Trump administration (Kue JD Vance and Kennedy's own deputy Jim O'Neill).
HHS response
The HHS quickly moved to shut down speculation, disappointing many of the Maha movement.
Children's Health Defense (CHD), a nonprofit founded by Kennedy, reported that “mRNA vaccine funds have not been cancelled,” citing HHS deputy reporter Emily G. Hilliard.
The NIH claims itself as “the largest public funder of the world's largest biomedical research.”
According to the CHD report
According to KFF Health News, NIH funds at least 130 studies, including mRNA technology, examining treatments for diseases such as influenza, AIDS and cancer. A clinical trial is also underway to study melanoma and Zika mRNA vaccines, according to the KFF Health News report on March 8th.
Funds
NIH does not always disclose specific financial details of the grant. Their sizes vary widely, with some over $500,000 in direct costs per year.
For example, the RNA Modification (Rnamodo) initiative to promote tumorigenesis is expected to receive $4.9 million per year for five years, totaling $24.5 million. We hope each will win an award of up to $650,000 per year at direct cost.
Similarly, NIH's research field 001, which funds treatments, vaccines and diagnosis of antibiotic-resistant pathogens, has up to $8.5 million initial funding with a budget of one to two contracts.
Another example is that on the last day of the Biden administration, HHS awarded MODENA a $590 million grant, accelerating the development of mRNA-based pandemic influenza vaccines, including those targeting avian flu strains. Although certain periods of this grant remain private, it is probably a multi-year project.
And it's not just NIH to fund such projects. In particular, the $4.7 billion “Project Nextgen” initiative designed to develop the next generation of covid vaccines remains intact. It is operated by the Biomedical Advanced Research and Development Agency (BARDA) of HHS.
Certainly, without specific financial data for each project, it is difficult to provide an accurate total estimate of all mRNA studies. However, it is clear that collective investment is substantial.
mRNA under investigation
Following the disastrous aftermath of the deployment of mRNA-based Covid vaccines, the platform faces an increase call to halt its development completely.
The CHD report features medical professionals seeking to close mRNA research. Epidemiologist Nicholas Halsher accused the platform of failure that caused catastrophic harm, urging policymakers to stop further development.
Dr. Clayton J. Baker, an internal medicine physician, criticized the billions of taxpayer funding spent on mRNA vaccines, claiming they offered little rebate. “What did taxpayers get in return? Two ineffective community products with the most reported deaths and injuries in history,” he said. He warned that mRNA has multiple mechanisms of harm and called on the government to stop funding the research.
Dr. Vinai Prasad, professor of epidemiology and biostatistics at the University of California, San Francisco, outlined five reasons why mRNA vaccine research should be “deprived.” He points to viable non-mRNA alternatives, unknown long-term safety risks, and damaged public reputation.
Psychotherapist Dr. Joseph Santhorne led legal efforts to ban Florida's mRNA vaccines and called for an immediate halt of funding.
“All funds for mRNA should be stopped soon,” he said, insisting that Kennedy bans mRNA injections and “ends symbiotic emergency in the same way that the president can quickly reverse the previous president's executive order.”
Kennedy's misconduct
Kennedy's failure to act on an mRNA-based covid vaccine has frustrated the Maha movement.
He has not taken action despite having the authority to amend or revoke the Public Preparation and Emergency Preparation (PREP) Act, which protects vaccine manufacturers from liability until December 31, 2029.
Additionally, certain COVID vaccines, including boosters and pediatric doses, still have emergency use permits (EUAs) under the purview. Under Section 564 of the Federal Food, Drugs and Cosmetics Act, Kennedy was able to revoke these EUAs.
State efforts
Kennedy's past priorities and campaign rhetoric is quickly becoming history. The man who once raileted against corporate capture and Big Pharma oversees the very equipment he once vowed to overhaul. So far, we have maintained the status quo.
The Constitution never imagined HHS, but grew into a bureaucratic giant with unidentified authority over public health. It will decide healthcare policy, protect the drug giant from liability, burn more than $1 trillion a year.
Fortunately, some states are pushing back. Florida took the lead and surgeon General Joseph Radapop called for the mRNA to be stopped. Lawmakers in Idaho, Montana and Kentucky have introduced legislation that would ban mRNA vaccines and fine doctors who administer them. Tennessee and North Dakota are considering limiting state funding for mRNA-based treatments. Others are pushing to label laws warning consumers of potential risks.
A complete ban has not been implemented yet, but resistance is increasing. Although Washington has refused to act, the state has proven that it still has a say in its fight against federal overreach.
RFK, Jr. Covid Optics: One trial pauses and vaccine agenda advances
We are seeking the RFK Jr. MMR vaccination. What about his past safety warnings?
RFK, Jr.
Yale Research links the Covid vaccine to chronic disease